Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

New portable device may hold key to accurately detecting Zika virus

About the size of a tablet, a portable device that could be used in a host of environments like a busy airport or even a remote location in South America, may hold the key to detecting the dreaded Zika virus accurately, rapidly and inexpensively using just a saliva sample.

22 Feb 2017

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

The IncuCyte® live-cell analysis platform from Essen BioScience will be showcased at the upcoming AACR conference, booth #1365.

From Sartorius 22 Feb 2017

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, researchers at The University of Texas MD Anderson Cancer Center report at the ASCO-Society for Immunotherapy in Cancer meeting in Orlando.

22 Feb 2017

Investigational malaria vaccine protects against multiple strains, study shows

An investigational malaria vaccine has protected a small number of healthy U.S. adults from infection with a malaria strain different from that contained in the vaccine, according to a study published today in the Proceedings of the National Academy of Sciences.

22 Feb 2017

New range of antibodies released by Cambridge Research Biochemicals®

Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB’s expansion and relocation which took place in January 2014 and secures the company’s position as a key player in the life science industry as we enter 2017.

21 Feb 2017

Penn researchers find new way to track rare T cells in blood after annual flu vaccine

For most vaccines to work the body needs two cell types - B cells and T helper cells - to make antibodies. B cells are the antibody factories and the T helper cells refine the strength and accuracy of antibodies to home and attack their targets.

20 Feb 2017

Research provides more evidence that mRNA vaccines can protect mice against Zika virus

Vaccine developers have successfully protected mice against Zika by injecting synthetic messenger RNA that encodes for virus proteins into the animals.

17 Feb 2017

DNA computer could be important step towards development of smart, 'intelligent' drugs

Researchers at Eindhoven University of Technology present a new method that should enable controlled drug delivery into the bloodstream using DNA computers.

17 Feb 2017

New research provides clues to how antibody treatment led to remission in SIV-infected monkeys

Scientists at the National Institutes of Health have found that the presence of the protein alpha-4 beta-7 integrin on the surface of HIV and its monkey equivalent--simian immunodeficiency virus, or SIV--may help explain why an antibody protected monkeys from SIV in previous experiments.

16 Feb 2017

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

More than six decades after Castleman disease was first described, a group of experts from Penn Medicine and other institutions around the world has established the first set of diagnostic criteria for a life-threatening subtype of the condition, idiopathic multicentric CD, which is often misdiagnosed as other illnesses.

16 Feb 2017

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

A pair of scientists from the Florida campus of The Scripps Research Institute have been awarded up to $3.3 million from the National Cancer Institute of the National Institutes of Health to create the next generation of breast cancer treatments for the thousands of patients whose current treatment options are limited.

14 Feb 2017

Plant-based drug for hemophilia shows promise in animal models

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

13 Feb 2017

Researchers identify molecular signatures to predict efficacy of malaria vaccines

The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.

13 Feb 2017

New discovery could lead to more effective malaria vaccine

A team at the Wellcome Trust Sanger Institute has discovered how a promising malarial vaccine target - the protein RH5 - helps parasites to invade human red blood cells.

11 Feb 2017

Mayo Clinic study quantifies immune cell types linked to future risk of developing breast cancer

Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.

8 Feb 2017

New antibody drug shows promising results to prevent or treat HIV

A new biologic agent--the most potent of its kind so far--is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.

7 Feb 2017

New discovery could lead to development of new cancer treatments

Macrophages are a type of white blood cell that can engulf and destroy cancer cells. A research group led by Professor MATOZAKI Takashi, Associate Professor MURATA Yoji, and YANAGITA Tadahiko, discovered that by using an antibody for a particular protein found on macrophages, the macrophage is activated, and cancer cells are effectively eliminated.

6 Feb 2017

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Medicine.

6 Feb 2017

Parents can take eight steps to boost child's immunity, says family medicine specialist

No magic elixir can prevent children from developing occasional colds and viruses, but takings steps to boost their immune system can minimize their chances of catching every bug that winds its way through the daycare center or school.

3 Feb 2017

Researchers receive $2 million grant from PCORI to study effective treatment for children with KD

Kawasaki disease (KD) is an uncommon illness that affects blood vessels in the hearts of children

2 Feb 2017

Antibody News and Research

Further Reading

New portable device may hold key to accurately detecting Zika virus

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Investigational malaria vaccine protects against multiple strains, study shows

New range of antibodies released by Cambridge Research Biochemicals®

Penn researchers find new way to track rare T cells in blood after annual flu vaccine

Research provides more evidence that mRNA vaccines can protect mice against Zika virus

DNA computer could be important step towards development of smart, 'intelligent' drugs

New research provides clues to how antibody treatment led to remission in SIV-infected monkeys

Experts establish first set of diagnostic criteria for life-threatening idiopathic multicentric CD

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

Plant-based drug for hemophilia shows promise in animal models

Researchers identify molecular signatures to predict efficacy of malaria vaccines

New discovery could lead to more effective malaria vaccine

Mayo Clinic study quantifies immune cell types linked to future risk of developing breast cancer

New antibody drug shows promising results to prevent or treat HIV

New discovery could lead to development of new cancer treatments

Preterm babies given monoclonal antibody appear less likely to develop recurrent wheeze

Parents can take eight steps to boost child's immunity, says family medicine specialist

Researchers receive $2 million grant from PCORI to study effective treatment for children with KD

Accelerating therapeutic antibody discovery and development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo